Methscopolamine bromide is a synthetic anticholinergic agent within the tropane alkaloid class, primarily indicated for the treatment of urinary incontinence and as an adjunct therapy for motion sickness.… Read more
Methscopolamine bromide is a synthetic anticholinergic agent within the tropane alkaloid class, primarily indicated for the treatment of urinary incontinence and as an adjunct therapy for motion sickness. By acting as a muscarinic cholinergic receptor antagonist, it effectively modulates parasympathetic nervous system activity. This category includes high-quality reference standards of methscopolamine bromide, as well as its related pharmaceutical impurities, metabolites, and stable isotope-labelled compounds. These reference materials are critical for analytical testing, impurity profiling, and method validation within pharmaceutical laboratories. Utilizing these standards enables precise quantitative analysis and supports rigorous quality control protocols during drug development and stability studies, ensuring that therapeutic formulations meet strict regulatory requirements for safety and efficacy.